Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-complex protein 11-like protein 1 (TCP11L1) is a protein-coding gene and member of the TCP11 family, related to the canonical t-complex protein 11 (TCP11) that has known functions in sperm motility and spermatogenesis in the mouse. TCP11L1 contains a conserved TCP11 protein domain and is predicted to participate in signal transduction processes and localizes to microtubules. Unlike TCP11, which is testis-specific, TCP11L1 appears to have a broader tissue expression. The precise molecular role of TCP11L1 remains uncharacterized, and it is not known to be a therapeutic target or directly implicated in major disease processes. Existing data mainly identify it as a structural or regulatory protein rather than as a receptor, enzyme, or drug target[3][4][7]. If you require a specific therapeutic target or receptor, TCP11L1 is not classified as such based on current evidence. No interacting drugs, defined disease mechanisms, or major biomarker applications have been reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-complex protein 11-like protein 1 (TCP11L1).